Volume 64, Issue 2, Pages (August 2003)

Slides:



Advertisements
Similar presentations
Kamyar Kalantar-Zadeh  Kidney International 
Advertisements

Acid-base profile in patients on PD
Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.
Reduced renal function in patients with simple renal cysts
Optimization of pre-ESRD care: The key to improved dialysis outcomes
Volume 65, Issue 6, Pages (June 2004)
Volume 54, Issue 2, Pages (August 1998)
Acid-base profile in patients on PD
Volume 84, Issue 5, Pages (November 2013)
End-stage renal disease in developing countries
Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis  James F. Medcalf, Kevin P.G.
Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.
Incremental peritoneal dialysis: Effects on the choice of dialysis modality, residual renal function and adequacy  G. Viglino, L. Neri, S. Barbieri  Kidney.
A dialysis patient with a nodular tongue
The risk of hospitalization and modality failure with home dialysis
C-reactive protein and dialysis access
Volume 68, Issue 5, Pages (November 2005)
Ho-Han Wu, Szu-Yuan Li, Wu-Chang Yang  Kidney International 
Fluid overload and residual renal function in peritoneal dialysis: the proof of the pudding is in the eating  Wim Van Biesen, Achim Jörres  Kidney International 
Volume 88, Issue 2, Pages (August 2015)
Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis  Sanjeev Kumar, Stanley L.-S. Fan, Martin.
Normalization of Protein Intake by Body Weight and the Associations of Protein Intake With Nutritional Status and Survival  Srinivasan Beddhu, MD, Nirupama.
Kamyar Kalantar-Zadeh  Kidney International 
Volume 73, Issue 4, Pages (February 2008)
Comorbidity and confounding in end-stage renal disease
Early mortality in dialysis and adequacy of predialysis renal care: the picture is more complex than we thought  Nicolas Rognant, Maurice Laville  Kidney.
Volume 67, Issue 5, Pages (May 2005)
Volume 77, Issue 2, Pages (January 2010)
Long-term study of mycophenolate mofetil treatment in IgA nephropathy
Volume 60, Issue 1, Pages (July 2001)
Volume 73, Pages S5-S17 (April 2008)
Acute myocardial infarction in patients with end-stage renal disease
Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.
Volume 58, Issue 2, Pages (August 2000)
Prescribing and monitoring hemodialysis dose
Volume 54, Issue 2, Pages (August 1998)
Volume 65, Issue 6, Pages (June 2004)
Peritoneal dialysis adequacy and risk of death
Volume 76, Issue 6, Pages (September 2009)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Abdulla K. Salahudeen, Erwin H. Fleischmann, John D. Bower 
Microbiology and outcomes of peritonitis in North America
Nephrology Crossword: Peritoneal Dialysis
Cardiovascular disease in pediatric chronic dialysis patients
Randomized long-term evaluation of bicarbonate-buffered CAPD solution
Alfonso M. Cueto-Manzano, Ricardo Correa-Rotter  Kidney International 
Reduced renal function in patients with simple renal cysts
Volume 73, Pages S72-S75 (April 2008)
Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis  N.-Y. Zalunardo, C.-L. Rose, I.W.Y.
Terry Behrend, Steven B. Miller, M.D  Kidney International 
Volume 59, Issue 6, Pages (June 2001)
Quality of life in peritoneal dialysis patients: Decline over time and association with clinical outcomes  Sr. Anne B. Bakewell, Rob M. Higgins, Mair.
Volume 70, Issue 3, Pages (August 2006)
Dialysis dose and gender: A different hypothesis
Daily nocturnal home hemodialysis
Racial differences in survival of patients on dialysis
Volume 58, Issue 1, Pages (July 2000)
Volume 70, Pages S84-S90 (November 2006)
Does equal care give equal outcomes?
Volume 80, Issue 10, Pages (November 2011)
Charles A. Herzog  Kidney International 
Volume 68, Issue 1, Pages (July 2005)
H.J. Chin, H. Ro, H.J. Lee, K.Y. Na, D.-W. Chae  Kidney International 
Volume 70, Issue 10, Pages (November 2006)
The International Pediatric Peritonitis Registry: Starting to walk
Volume 65, Issue 5, Pages (May 2004)
Survival of propensity matched incident peritoneal and hemodialysis patients in a United States health care system  Victoria A. Kumar, Margo A. Sidell,
Optimization of pre-ESRD care: The key to improved dialysis outcomes
Stephen Pastan, J. Michael Soucie, William M. McClellan 
Presentation transcript:

Volume 64, Issue 2, Pages 649-656 (August 2003) Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study  Wai-Kei Lo, Yiu-Wing Ho, Chun-Sang Li, Kin-Shing Wong, Tak-Mao Chan, Alex Wai-Yin Yu, Flora So-King Ng, Ignatius Kum-Po Cheng  Kidney International  Volume 64, Issue 2, Pages 649-656 (August 2003) DOI: 10.1046/j.1523-1755.2003.00098.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 The mean total, renal, and peritoneal Kt/V of the groups at different time points of study. The error bar depicts 95% CI of the mean. (A) Total Kt/V, the P values of the difference were 0.000 from 1month 1 onward. (B) Renal Kt/V, there was no statistical difference in renal Kt/V among the three groups except at 7months (P = 0.029) and 19months (P = 0.017). (C) Peritoneal Kt/V, the P values of the difference were 0.000 from 1month onward. Symbols are: (□) group A; (▪) group B; and (○) group C. Kidney International 2003 64, 649-656DOI: (10.1046/j.1523-1755.2003.00098.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 The mean total Kt of the groups at different time points of study. The error bar depicts 95% CI of the mean. The difference between groups was significant from 1month to 25months (P = 0.000). Symbols are: (□) group A; (▪) group B; (○) group C. Kidney International 2003 64, 649-656DOI: (10.1046/j.1523-1755.2003.00098.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 3 The daily peritoneal dialysis fluid prescription of the groups at different time points of study. The error bar depicts 95% CI of the mean. The difference between groups was significant from 1month to 25months (P = 0.000 for months 1 to 19, and P = 0.002 for month 25). Symbols are: (□) group A; (▪) group B; (○) group C. Kidney International 2003 64, 649-656DOI: (10.1046/j.1523-1755.2003.00098.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 4 Cumulative patient survival of the three groups. The difference was not statistically significant (P = 0.9924). Kidney International 2003 64, 649-656DOI: (10.1046/j.1523-1755.2003.00098.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 5 Cumulative clinical survival of the three groups. The difference was not statistically significant (P = 0.1580). The difference in 2-year survival between groups A and B was marginally insignificant (P = 0.054). Kidney International 2003 64, 649-656DOI: (10.1046/j.1523-1755.2003.00098.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 6 The mean serum albumin level of the three groups at different time points of study. The error bar depicts 95% CI of the mean. The difference was not significant at other time points. Symbols are: (□) group A; (▪) group B; (○) group C. Kidney International 2003 64, 649-656DOI: (10.1046/j.1523-1755.2003.00098.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 7 The mean composite nutritional index (CNI) scores of the three groups at different time points of study. The error bar depicts 95% CI of the mean. The difference was not significant at other time points. Symbols are: (□) group A; (▪) group B; (○) group C. Kidney International 2003 64, 649-656DOI: (10.1046/j.1523-1755.2003.00098.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 8 The mean normalized protein catabolic rate (nPCR) of the three groups at different time points of study. The error bar depicts 95% CI of the mean. At 7months, the difference was significant between groups A and B (P = 0.014) but not between groups B and C. The difference was not significant at other time points. Symbols are: (□) group A; (▪) group B; (○) group C. Kidney International 2003 64, 649-656DOI: (10.1046/j.1523-1755.2003.00098.x) Copyright © 2003 International Society of Nephrology Terms and Conditions